These lab-created alternate options weren't formulated with leisure use in your mind. During the 1990s, John W. Huffman plus a staff of fellow chemists at Clemson University established some of the initial formulation for artificial cannabinoid receptor agonists (SCRAs), a family of substances that imitate the physiological and psychological impact